Market Research Logo

Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review

Section 1 - About the Company 5
Yuhan Corp - Key Facts 5
Yuhan Corp - Key Employees 6
Yuhan Corp - Major Products and Services 7
Yuhan Corp - History 8
Yuhan Corp - Company Statement 10
Yuhan Corp - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Affiliate 12
Joint Venture 12
Section 2 – Company Analysis 13
Yuhan Corp - Business Description 13
Yuhan Corp - Corporate Strategy 14
Yuhan Corp - SWOT Analysis 15
SWOT Analysis - Overview 15
Yuhan Corp - Strengths 15
Yuhan Corp - Weaknesses 16
Yuhan Corp - Opportunities 17
Yuhan Corp - Threats 18
Yuhan Corp - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Yuhan Corp, Recent Deals Summary 29
Section 5 – Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
Yuhan Corp, Key Facts 5
Yuhan Corp, Key Employees 6
Yuhan Corp, Major Products and Services 7
Yuhan Corp, History 8
Yuhan Corp, Other Locations 11
Yuhan Corp, Subsidiaries 11
Yuhan Corp, Affiliate 12
Yuhan Corp, Joint Venture 12
Yuhan Corp, Key Competitors 19
Yuhan Corp, Ratios based on current share price 20
Yuhan Corp, Annual Ratios 21
Yuhan Corp, Annual Ratios (Cont...1) 22
Yuhan Corp, Annual Ratios (Cont...2) 23
Yuhan Corp, Interim Ratios 25
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Yuhan Corp, Recent Deals Summary 29
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33
List of Figuress
Yuhan Corp, Performance Chart (2012 - 2016)
Yuhan Corp, Ratio Charts
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. The company provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. It offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report